<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>357</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>11601848</PubmedId>
            <Abstract>The outstanding importance of the antigen-antibody recognition process for the survival and defence strategy of higher organisms is in sharp contrast to the limited high resolution structural data available on antibody-antigen pairs with antigenic proteins. The limitation is the most severe for structural data not restricted to the antigen-antibody complex but extending to the uncomplexed antigen and antibody. We report the crystal structure of the complex between tissue factor (TF) and the humanized Fab fragment D3h44 at a resolution of 1.85 A together with the structure of uncomplexed D3h44 at the same resolution. In conjunction with the previously reported 1.7 A crystal structure of uncomplexed TF, a unique opportunity is generated to explore details of the recognition process. The TF.D3h44 interface is characterised by a high number of polar interactions, including as may as 46 solvent molecules. Conformational changes upon complex formation are very small and almost exclusively limited to the reorientation of side-chains. The binding epitope is in complete agreement with earlier mutagenesis experiments. A revaluation of two other antibody-antigen pairs reported at similar resolutions, shows that all these complexes are very similar with respect to the solvation of the interface, the number of solvent positions conserved in the uncomplexed and complexed proteins and the number of water molecules expelled from the surface and replaced by hydrophilic atoms from the binding partner upon complex formation. A strategy is proposed on how to exploit this high resolution structural data to guide the affinity maturation of humanised antibodies.</Abstract>
            <ArticleYear>2001</ArticleYear>
            <ArticlePages>83-97</ArticlePages>
            <ArticleTitle>The 1.85 A resolution crystal structures of tissue factor in complex with humanized Fab D3h44 and of free humanized Fab D3h44: revisiting the solvation of antigen combining sites.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Faelber</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Kirchhofer</LastName>
                    <ForeName>D</ForeName>
                </Author>
                <Author>
                    <LastName>Presta</LastName>
                    <ForeName>L</ForeName>
                </Author>
                <Author>
                    <LastName>Kelley</LastName>
                    <ForeName>R F</ForeName>
                </Author>
                <Author>
                    <LastName>Muller</LastName>
                    <ForeName>Y A</ForeName>
                </Author>
            </Authors>
            <ArticleChemicalList>Immunoglobulin Fab Fragments;Solvents;Water;Thromboplastin</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Binding Sites, Antibody; Crystallography, X-Ray; Humans; Immunoglobulin Fab Fragments(chemistry; immunology; metabolism); Models, Molecular; Molecular Sequence Data; Protein Structure, Tertiary; Solvents; Thromboplastin(chemistry; immunology; metabolism); Water(chemistry; metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>313</Volume>
                <Issue>1</Issue>
                <Title>Journal of molecular biology</Title>
                <Issn>1089-8638</Issn>
                <MedlineTa>J Mol Biol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>D3h44 Fab epitope on Tissue Factor</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>K181, I184, T186, Y188, G196, K197, K198,T199, A200, K201,T202, N203, E206, L208, D210, S220, Q222, V224, P226, R228, T229, V230, N231, R232, K233, S234, T235, D236</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P13726.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2</LocationOfData>
                <EpitopeId>177383</EpitopeId>
                <ReferenceRegion>K149, I152, T154, Y156, G164, K165, K166, T167, A168, K169, T170, N171, E174, L176, D178, S188, Q190, V192, P194, R196, T197, V198, N199, R200, K201, S202, T203, D204</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 2, 3, Tables 1, 2 and PDB 1JPS</LocationOfData>
                        <BCellId>1491387</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P13726.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>partially purified native rTF</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <DoseSchedule>1 dose of 180 ug and a boost with thrombin-cleaved gDTF fusion protein</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the parent murine monoclonal antibody D3 was previously described in the cited reference: Paborsky et al. (1990) Protein Eng  3(6): 547-553  [PMID: 2164668]. The parent D3 was obtained from mice that received a first immunization of partially purified native recombinant TF, and a boost with thrombin-cleaved TF-Herpes simplex virus glycoprotein D fusion proten. MAb D3 was humanized and affinity matured to mAb D3h44 by grafting the CDR regions into a human IgG1-kappa scaffold as described in Presta et al. (2001) Thromb Haemost 85(3): 379-389 [PMID: 11307801].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.85</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of humanized D3h44 Fab on human Tissue factor ectodomain was determined from the crystal  structure of the complex.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Antibody construct</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>humanized D3h44</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>humanized antibody D3h44</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1JPS_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1JPS_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Extracellular domain of Tissue factor</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SGTTNTVAAYNLTWKSTNFKTILEWEPKPVNQVYTVQISTKSGDWKSKCFYTTDTECDLTDEIVKDVKQTYLARVFSYPAGNVESTGSAGEPLYENSPEFTPYLETNLGQPTIQSFEQVGTKVNVTVEDERTLVRRNNTFLSLRDVFGKDLIYTLYYWKSSSSGKKTAKTNTNEFLIDVDKGENYCFSVQAVIPSRTVNRKSTDSPVECMGQEKGEFRE</LinearSequence>
                                        <StartingPosition>33</StartingPosition>
                                        <EndingPosition>251</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P13726.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1JPS</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>T</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>There are no conformational changes for bound TF compared with free TF [PDB: 2HFT], and for bound D3h44 Fab compared with unbound [PDB: 1JPT]. Complexes 5G9 Fab/TF [PDB: 1AHW] and this complex D3h44 Fab/TF [PDB: 1JPS] can be superimposed with r.m.s.d. of 1.71 &amp;Ang; using all C-alpha atoms. Paratopes and epitopes for complexes 5G9 Fab/TF and D3h44 Fab/TF are almost identical.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>T: K149, I152, T154, Y156, G164, K165, K166, T167, A168, K169, T170, N171, E174, L176, D178, S188, Q190, V192, P194, R196, T197, V198, N199, R200, K201, S202, T203, D204</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>L: R27:L1, K30:L1, Y32:L1, Y50:L2, H91:L3, G92:L3, E93:L3, S94:L3, W96:L3; H: K30:H1, E31:H1, Y32:H1, Y33:H1, L50:H2, D52:H2, E54:H2, Q55:H2, N57:H2, T58:H2, I59:H2, Y60:H2, Q65:H2, D99:H3, T100:H3, A101:H3, A102:H3;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>930.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>920.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>T: I152, T154, Y156, G164, K165, K166, T167, A168, K169, T170, N171, Q190, V192, P194, T197, V198, N199, R200, K201, T203, D204</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: K30, E31, Y32, Y33, D52, E54, Q55, N57, I59, Q65, T100, A101, A102; L: Y32, Y50, H91, G92, E93, S94, W96</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>933.4</ContactAreaForAntigen>
                                <ContactAreaForAntibody>919.0</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

